Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
The aim of the study is to compare a customized facemask for the treatment of Class III malocclusion in the prepubertal growing patient (patients between the ages of 5 and 12 years) versus a standard commercial facemask. Specifically, preference, pain, difficulty in sleeping, time of use, and possible complications for the two types of facemasks will be analyzed. This is a single-center, national, controlled, superiority, randomized, crossover, open-label study. Each patient will be treated with both the customized facemask and the standard commercial facemask. Each patient will wear one type of facemask for 2 months and the other type of facemask for the next 2 months. After 2 weeks and at the end of therapy with each of the facemask types, the patient, with the possible help of the parents, will have to answer a questionnaire about pain and difficulty sleeping and report any complications. In addition, after completing both phases (fourth month), the patient should indicate a preference for one of the two types of mask with which to complete therapy for an additional 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2024
CompletedFirst Posted
Study publicly available on registry
May 7, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJuly 31, 2024
July 1, 2024
4 months
May 2, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Questionnaire on the preference of the patient for one of the two types of face masks
The primary endpoint is a questionnaire on the preference between the two types of face masks at the end of the second phase of therapy (4 months after delivery of the first face mask)
4 months
Secondary Outcomes (4)
Pain reported by patients
At 2 weeks and at 2 months after delivery of each of the 2 face masks
Difficulty in sleeping reported by patients
At 2 weeks and at 2 months after delivery of each of the 2 face masks
Number of complications
At 2 weeks and at 2 months after delivery of each of the 2 face masks
Total time wear
At 2 months after delivery of each of the 2 face masks
Study Arms (2)
Customized facemask
EXPERIMENTALStandard facemask
ACTIVE COMPARATORInterventions
The customized face mask will be fabricated from a 3D digital image of the patient's face obtained by means of a 3D scanner. Such a scanner consists of 6 digital SLR cameras and software capable of processing a 3-D image of the patient's face exportable as an stl file.
The standard facemask is the commercially available Petit standard facemask
Eligibility Criteria
You may qualify if:
- Age between 5 and 12 years;
- Class III malocclusion, for which early orthopedic treatment with rapid maxillary expander and facemask is indicated.
- signing of informed consent
You may not qualify if:
- Cleft lip and/or palate.
- Craniofacial syndromes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2024
First Posted
May 7, 2024
Study Start
September 1, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2026
Last Updated
July 31, 2024
Record last verified: 2024-07